摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopent-4'-ene | 208453-68-3

中文名称
——
中文别名
——
英文名称
(1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopent-4'-ene
英文别名
(1R,2S,5S)-5-(6-aminopurin-9-yl)cyclopent-3-ene-1,2-diol
(1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopent-4'-ene化学式
CAS
208453-68-3
化学式
C10H11N5O2
mdl
——
分子量
233.23
InChiKey
RQPALADHFYHEHK-VMHSAVOQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    180-181 °C
  • 沸点:
    556.8±60.0 °C(Predicted)
  • 密度:
    1.87±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    110
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    (1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopent-4'-eneplatinum(IV) oxide 氢气 作用下, 以 甲醇 为溶剂, 以58%的产率得到(1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopentane
    参考文献:
    名称:
    Does the Anti-Hepatitis B Virus Activity of (+)-5‘-Noraristeromycin Exist in Its 4‘-Epimer and 4‘-Deoxygenated Derivatives?
    摘要:
    To begin an exploration of the structural parameters responsible for the activity of (+)-5'-noraristeromycin toward hepatitis B virus (HBV), three derivatives varied at the C-4' position have been prepared and evaluated. The syntheses began with a Mitsunobu coupling reaction of an appropriate cyclopentanol with B-chloropurine. The products of these reactions were synthetically altered by standard ammonolysis and deprotection procedures to give the desired products. Evaluation of the new derivatives indicated that removal of the C-4' hydroxyl of (+)-5'-noraristeromycin increased its potency toward HBV by approximately 10-fold.
    DOI:
    10.1021/jm980038a
  • 作为产物:
    描述:
    (1'S,2'R,3'S)-9-[2',3'-(isopropylidenedioxy)cyclopent-4'-en-1'-yl]-6-chloro-9H-purine 在 Dowex 50X8 resin 、 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 (1'S,2'R,3'S)-1'-(6-amino-9H-purin-9-yl)-2',3'-dihydroxycyclopent-4'-ene
    参考文献:
    名称:
    Does the Anti-Hepatitis B Virus Activity of (+)-5‘-Noraristeromycin Exist in Its 4‘-Epimer and 4‘-Deoxygenated Derivatives?
    摘要:
    To begin an exploration of the structural parameters responsible for the activity of (+)-5'-noraristeromycin toward hepatitis B virus (HBV), three derivatives varied at the C-4' position have been prepared and evaluated. The syntheses began with a Mitsunobu coupling reaction of an appropriate cyclopentanol with B-chloropurine. The products of these reactions were synthetically altered by standard ammonolysis and deprotection procedures to give the desired products. Evaluation of the new derivatives indicated that removal of the C-4' hydroxyl of (+)-5'-noraristeromycin increased its potency toward HBV by approximately 10-fold.
    DOI:
    10.1021/jm980038a
点击查看最新优质反应信息

文献信息

  • Does the Anti-Hepatitis B Virus Activity of (+)-5‘-Noraristeromycin Exist in Its 4‘-Epimer and 4‘-Deoxygenated Derivatives?
    作者:Katherine L. Seley、Stewart W. Schneller、Brent Korba
    DOI:10.1021/jm980038a
    日期:1998.6.1
    To begin an exploration of the structural parameters responsible for the activity of (+)-5'-noraristeromycin toward hepatitis B virus (HBV), three derivatives varied at the C-4' position have been prepared and evaluated. The syntheses began with a Mitsunobu coupling reaction of an appropriate cyclopentanol with B-chloropurine. The products of these reactions were synthetically altered by standard ammonolysis and deprotection procedures to give the desired products. Evaluation of the new derivatives indicated that removal of the C-4' hydroxyl of (+)-5'-noraristeromycin increased its potency toward HBV by approximately 10-fold.
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦